How to Cite
Abstract
Vancomycin is an antimicrobial frequently used in hospitals for the treatment of serious infections due to methicillin-resistant Staphylococcus aureus, among its most important side effects is nephrotoxicity. This, in the presence of other risk factors specific to the patient, predisposes to the appearance of acute kidney injury.
Keywords
References
Mercado MG, Smith DK, Guard EL. Acute kidney injury: Diagnosis and management. Am Fam Physician [Internet]. 2019 [citado el 18 de marzo de 2022];100(11):687–94. Disponible en: https://pubmed.ncbi.nlm.nih.gov/31790176/
Levey AS, James MT. Acute kidney injury. Ann Intern Med [Internet]. 2017;167(9):ITC66. Disponible en: http://dx.doi.org/10.7326/aitc201711070
Jacob J, Dannenhoffer J, Rutter A. Acute kidney injury. Prim Care [Internet]. 2020;47(4):571–84. Disponible en: http://dx.doi.org/10.1016/j.pop.2020.08.008
Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat Rev Dis Primers [Internet]. 2021 [citado el 20 de marzo de 2022];7(1):52. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34267223/
Küllmar M, Zarbock A, Engelman DT, Chatterjee S, Wagner N-M. Prevention of acute kidney injury. Crit Care Clin [Internet]. 2020;36(4):691–704. Disponible en: http://dx.doi.org/10.1016/j.ccc.2020.07.002
Ebstein N, Gaudry S, Cohen Y. Tratamiento de la lesión renal aguda en cuidados intensivos (excluyendo la depuración renal). EMC - Anest-Reanim [Internet]. 2021;47(4):1–14. Disponible en: http://dx.doi.org/10.1016/s1280-4703(21)45674-4
Bamgbola O. Review of vancomycin-induced renal toxicity: an update. Ther Adv Endocrinol Metab [Internet]. 2016 [citado el 20 de marzo de 2022];7(3):136–47. Disponible en: https://pubmed.ncbi.nlm.nih.gov/27293542/
Filippone EJ, Kraft WK, Farber JL. The nephrotoxicity of vancomycin. Clin Pharmacol Ther [Internet]. 2017;102(3):459–69. Disponible en: http://dx.doi.org/10.1002/cpt.726
Tantranont N, Hebert S, Truong LD. Vancomycin nephrotoxicity causing renal transplant acute kidney injury. Transplant Proc [Internet]. 2021;53(10):2913–7. Disponible en: http://dx.doi.org/10.1016/j.transproceed.2021.09.033
Soares D de S, Reis A da F, Silva Junior GB da, Leite TT, Parente Filho SLA, Rocha CV de O, et al. Polymyxin-B and vancomycin-associated acute kidney injury in critically ill patients. Pathog Glob Health [Internet]. 2017;111(3):137–42. Disponible en: http://dx.doi.org/10.1080/20477724.2017.1309338
Pais GM, Liu J, Zepcan S, Avedissian SN, Rhodes NJ, Downes KJ, et al. Vancomycin-induced kidney injury: Animal models of toxicodynamics, mechanisms of injury, human translation, and potential strategies for prevention. Pharmacotherapy [Internet]. 2020;40(5):438–54. Disponible en: http://dx.doi.org/10.1002/phar.2388
Wang Y, Dai N, Wei W, Jiang C. Outcomes and nephrotoxicity associated with vancomycin treatment in patients 80 years and older. Clin Interv Aging [Internet]. 2021;16:1023–35. Disponible en: http://dx.doi.org/10.2147/CIA.S308878
Jeffres MN. The whole price of vancomycin: Toxicities, troughs, and time. Drugs [Internet]. 2017;77(11):1143–54. Disponible en: http://dx.doi.org/10.1007/s40265-017-0764-7
Blair M, Côté J-M, Cotter A, Lynch B, Redahan L, Murray PT. Nephrotoxicity from vancomycin combined with piperacillin-tazobactam: A comprehensive review. Am J Nephrol [Internet]. 2021;52(2):85–97. Disponible en: http://dx.doi.org/10.1159/000513742
Fiorito TM, Luther MK, Dennehy PH, LaPlante KL, Matson KL. Nephrotoxicity with vancomycin in the pediatric population: A systematic review and meta-analysis. Pediatr Infect Dis J [Internet]. 2018;37(7):654–61. Disponible en: http://dx.doi.org/10.1097/inf.0000000000001882
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2022 Array